Trial NCT04060862

View at ClinicalTrials.gov 
Org. Study IDs: CO41012
Secondary IDs: 2019-001072-11

Last trial update was posted on 2024-04-03

MeSH Interventions

Fulvestrant Ipatasertib Palbociclib

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

The decision to not open the Phase III portion was based on a strategic sponsor decision and not driven by any safety concerns.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID